Clal Biotechnology Industries (XTAE:CBI) Total Operating Expense: ₪4.72 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:CBI Clal Biotechnology Industries Ltd XTAE:CBI
18 GF Score
Price ₪0.24
! 3 Warning Signs
View Full Analysis

What is Clal Biotechnology Industries Total Operating Expense?

Clal Biotechnology Industries XTAE:CBI -0.42% 18 Total Operating Expense is ₪4.72 Mil as of Dec. 2025. GuruFocus rates XTAE:CBI with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Clal Biotechnology Industries's Total Operating Expense for the six months ended in Dec. 2025 was ₪2.24 Mil. Clal Biotechnology Industries's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was ₪4.72 Mil.

Clal Biotechnology Industries Total Operating Expense Related Terms

Clal Biotechnology Industries Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Clal Biotechnology Industries's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clal Biotechnology Industries Total Operating Expense Chart

Clal Biotechnology Industries Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.37 12.88 10.29 6.63 4.72

Clal Biotechnology Industries Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.57 3.59 3.03 2.49 2.24
XTAE:CBI
18GF Score
Clal Biotechnology Industries Ltd XTAE:CBI
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clal Biotechnology Industries Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪4.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₪4.72 Mil mean?
Clal Biotechnology Industries (XTAE:CBI) has a Total Operating Expense of ₪4.72 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Clal Biotechnology Industries and its competitors.
Is Clal Biotechnology Industries' Total Operating Expense too high?
Clal Biotechnology Industries' current Total Operating Expense is ₪4.72 Mil. Overall, Clal Biotechnology Industries has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Clal Biotechnology Industries' Total Operating Expense compare to VRTX and REGN?
Clal Biotechnology Industries' Total Operating Expense of ₪4.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Clal Biotechnology Industries and its competitors. Clal Biotechnology Industries's current Total Operating Expense is ₪4.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clal Biotechnology Industries stock overvalued right now?
Clal Biotechnology Industries (XTAE:CBI) has a current Total Operating Expense of ₪4.72 Mil. The current Total Operating Expense is ₪4.72 Mil. Clal Biotechnology Industries' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Clal Biotechnology Industries (XTAE:CBI), the current Total Operating Expense is ₪4.72 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clal Biotechnology Industries Business Description

Address Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.
18GF Score

Get the complete analysis for XTAE:CBI

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.24
Price